Company intelligence / Profile preview

Blue Note Therapeutics

San Francisco, California, United Statesprnewswire.com ↗

Ownership: Private
Development stage: Commercial

Overview

Blue Note Therapeutics developed prescription digital therapeutics aimed at reducing anxiety, depression, and distress in cancer patients. Its lead product, attune™, received Breakthrough Device designation from the FDA but failed to gain clearance after randomized controlled trial data did not meet regulatory requirements. The company ceased operations in 2024 following an unsuccessful appeal of the FDA's decision.

Therapeutic areas: OncologyPsychiatry
Modalities: Non-pharmacological therapyDevice
Industry: Digital Health Medical Devices

Drug pipeline

2 assets

BNT001

Phase 2

Indications: Cancer-related anxiety, Cancer-related depression

1 more asset in the full pipeline.

Request access →

Partnerships

OncoHealth (integration into Iris™ telehealth platform)Curebase (virtual clinical trials collaboration)Memorial Sloan Kettering Cancer Center ("Innovation Hub" collaboration on fear-of-recurrence PDT candidate)

Beyond the preview

Go deeper on Blue Note Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blue Note Therapeutics.

Explore the full profile